AMF Tjanstepension AB Buys Shares of 6,424 Agilent Technologies, Inc. $A

AMF Tjanstepension AB bought a new stake in Agilent Technologies, Inc. (NYSE:A) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm bought 6,424 shares of the medical research company’s stock, valued at approximately $874,000.

Several other hedge funds have also recently bought and sold shares of A. Massachusetts Financial Services Co. MA boosted its stake in shares of Agilent Technologies by 13.8% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock valued at $1,925,064,000 after purchasing an additional 1,713,216 shares in the last quarter. AQR Capital Management LLC boosted its stake in shares of Agilent Technologies by 424.1% in the 2nd quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock valued at $240,956,000 after purchasing an additional 1,652,244 shares in the last quarter. Ameriprise Financial Inc. boosted its stake in shares of Agilent Technologies by 132.2% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock valued at $277,807,000 after purchasing an additional 1,340,161 shares in the last quarter. SG Americas Securities LLC boosted its stake in shares of Agilent Technologies by 3,091.1% in the 4th quarter. SG Americas Securities LLC now owns 808,215 shares of the medical research company’s stock valued at $109,974,000 after purchasing an additional 782,888 shares in the last quarter. Finally, Lazard Asset Management LLC boosted its stake in shares of Agilent Technologies by 639.4% in the 2nd quarter. Lazard Asset Management LLC now owns 678,718 shares of the medical research company’s stock valued at $80,093,000 after purchasing an additional 586,931 shares in the last quarter.

Agilent Technologies Price Performance

NYSE A opened at $112.05 on Tuesday. The company has a market cap of $31.66 billion, a PE ratio of 24.73, a price-to-earnings-growth ratio of 2.35 and a beta of 1.22. Agilent Technologies, Inc. has a 52 week low of $107.07 and a 52 week high of $160.27. The company has a quick ratio of 1.59, a current ratio of 2.07 and a debt-to-equity ratio of 0.44. The firm’s 50-day simple moving average is $114.94 and its two-hundred day simple moving average is $130.33.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing the consensus estimate of $1.37 by ($0.01). The company had revenue of $1.80 billion for the quarter, compared to the consensus estimate of $1.81 billion. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The company’s quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. Research analysts predict that Agilent Technologies, Inc. will post 5.95 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the stock. UBS Group decreased their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. HSBC began coverage on shares of Agilent Technologies in a research note on Tuesday, January 20th. They set a “buy” rating and a $180.00 price target for the company. Wells Fargo & Company cut their price objective on shares of Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a report on Thursday, February 26th. Wall Street Zen downgraded shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Saturday, May 9th. Finally, Morgan Stanley cut their price objective on shares of Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating on the stock in a report on Tuesday, March 3rd. Two analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, Agilent Technologies has a consensus rating of “Buy” and an average target price of $163.71.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.